Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aspira Women's Health Inc. (AWHL) vs ENDRA Life Sciences Inc. (NDRA)

Aspira Women's Health Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $8.9M against $2.4M — 3.6× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −117.1%) and the lower return on invested capital (−539.9% vs 0.00%). Across the 15 metrics below, Aspira Women's Health Inc. leads on 9 and ENDRA Life Sciences Inc. on 6.

Valuation

Metric AWHL NDRA Diagnostics & Research median
P/E n/m n/m 33.95
P/S 1.35 22.35 4.87
P/B n/m 1.27 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 1.52 7.61 5.66
Earnings yield (93.85%) (104.64%) (1.75%)
Free cash flow yield (41.10%) (98.06%) (0.13%)

Profitability

Metric AWHL NDRA Diagnostics & Research median
Gross margin 58.78% 0.00% 50.89%
Operating margin (80.75%) 0.00% (8.57%)
Net margin (117.07%) 0.00% (6.37%)
Free cash flow margin (55.32%) 0.00% 0.00%
Return on equity 201.29% (152.04%) (2.92%)
Return on assets (213.58%) (110.08%) (6.71%)
Return on invested capital 0.00% (539.89%) 0.00%

Growth

Metric AWHL NDRA Diagnostics & Research median
Revenue growth (TTM) (8.00%) — 7.69%
EPS growth (last fiscal year) 60.22% 84.32% —
Revenue growth, 5-year CAGR 14.66% — 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL NDRA Diagnostics & Research median
Debt to equity (0.27) 0.00 0.11
Current ratio 0.52 7.10 2.02
Net debt to EBITDA 0.00 0.14 0.78

Dividend

Metric AWHL NDRA Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AWHL NDRA Diagnostics & Research median
Market cap 2.44m 8.89m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack